ScoutBio raises $20 mln
ScoutBio said April 10 that it raised $20 million in Series B financing co-led by Digitalis Ventures’ Companion Fund and RiverVest Venture Partners. GreenSpring Associates as well as existing investors Frazier Healthcare Partners, Adage Capital Management and Correlation Ventures participated in the round. ScoutBio is a biotech focused on pet medicine that aims to deliver a pipeline of one-time therapeutics for major chronic pet health conditions.
10 April 2019•5 mins read
